Pharmaceutical formulation containing an HMG-CoA reductase inhibitor and method for the preparation thereof

Details for Australian Patent Application No. 2006343499 (hide)

Owner Pharmathen S.A.

Inventors Ioannidou, Elisavet; Bikiaris, Dimitrios; Karavas, Evangelos; Stathaki, Eleni; Koutris, Efthimios

Agent Spruson & Ferguson

Pub. Number AU-A-2006343499

PCT Pub. Number WO2007/131517

Filing date 12 May 2006

Wipo publication date 22 November 2007

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2007/131517 Priority application(s): WO2007/131517

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006343524-Plasma actuators for drag reduction on wings, nacelles and/or fuselage of vertical take-off and landing aircraft

2006343492-A controllable device, a kit and a method for treatment of disorders in the heart rhythm regulation system